Table 3.
Sites of Co-Infections
| Co-Infection | Total (n=74) |
|---|---|
| Infective sites | |
| Lung, n (%) | 55 (74.3) |
| Abdominal cavity, n (%) | 2 (2.7) |
| Blood stream, n (%) | 1 (1.4) |
| Disseminated infection, n (%) | 16 (21.6) |
| Lung + Blood stream, n (%) | 4 (5.4) |
| Lung + Skin/mucosa, n (%) | 4 (5.4) |
| Lung + Abdominal cavity, n (%) | 2 (2.7) |
| Lung + Esophagus, n (%) | 1 (1.4) |
| Lung + Abdominal cavity + Blood stream, n (%) | 1 (1.4) |
| Lung + Abdominal cavity + Urinary tract, n (%) | 2 (2.7) |
| Lung + Blood stream + Urinary tract, n (%) | 1 (1.4) |
| Lung + Abdominal cavity + Blood stream + Urinary tract, n (%) | 1 (1.4) |
Abbreviation: IPA, invasive pulmonary aspergillosis.